期刊文献+

两种^(99)Tc^m标记双功能螯合剂:NHS-MAG3和HYNIC 被引量:3

Two bifunctional chelating agents used in ^(99)Tc^m labeling:NHS-MAG3 and HYNIC
下载PDF
导出
摘要 99Tcm在标记蛋白、核酸、多肽和抗体时,常采用双功能螯合剂作为偶联剂的间接标记法,以避免直接标记所带来的损伤。研究表明,近年来常用的两种螯合剂NHS-MAG3及HYNIC合成路线清晰,偶联及标记方法成熟,标记率、放化纯及比活度较高,为核素分子显像提供了必要的基础条件和广阔的临床应用前景。 When protein, nucleic acid, polypeptide and antibody labeled with 99Tcm, bifunctional chelating agents(BFCA)are commonly used in order to avoid damages by directly labeling. We choose two BFCA:NHS-MAG3 and HYNIC as representation. The synthesis of these two BFCA is clear and the meth-ods of conjugating and labeling are mature. Through BFCA we can gain high radiolabeling yield, radiochemi-cal purity and specific activity. The usage of BFCA can provide necessary condition for molecular imaging and extensively clinical foreground.
作者 兰晓莉
出处 《国外医学(放射医学核医学分册)》 2005年第1期15-18,共4页 Foreign Medical Sciences(Section of Radiation Medicine and Nuclear Medicine)
基金 国家自然科学基金项目(30271439) 高等学校博士点基金项目(20030487013)
  • 相关文献

参考文献20

  • 1齐传民,郭雪峰,张华北,李波,冯淑娟,杨凌春.新N_3S型类肽配体的合成及其小鼠体内的生物分布研究[J].药学学报,2002,37(6):428-432. 被引量:5
  • 2高再荣,张凯军,张永学.Survivin反义寡核苷酸的^(99m)Tc标记及在肝癌细胞中的表达[J].放射学实践,2004,19(1):50-52. 被引量:3
  • 3Winnard P Jr, Chang F, Rusekowski M, et al. Preparation and use of NHS-MAG3 for technetium-99m labeling of DNA[J]. Nucl Med Biol, 1997, 24(5): 425-432.
  • 4Hnatowich D J, Qu T, Chang F, et al. Labeling peptide with technetium-99m using a bifunctional chelator of a N-hydroxysuc-cinimide ester of mercaptoacetyltrigycine[J]. J Nucl Med, 1998,39(1): 56-64.
  • 5Gano L, Patry'cio L, Marques E, et al. Human polyclonal immunoglobulin labelled with technetium-99m via NHS-MAG3: A comparisonof radiochemical behavior and biological efficacy with other labelling methods[J]. Nucl Med Bio1,1998, 25(4): 395-403.
  • 6Lei K, Rusckowski M, Chang F, et al. Technetium-99m antibodies labeled with MAG3 and SHNH: an in vitro and animal in vivo comparison[J]. Nucl Med Biol, 1996, 23(7): 917-922.
  • 7Wang Y, Chang F, Zhang Y, et al. Pretargeting with amplification using polymeric peptide nucleic acid[J]. Bioconjug Chem, 2001, 12(5): 807-816.
  • 8Liu G, Zhang S, He J, et al. Improving the labeling of S-acetyl NHSMAG (3)-conjugated morpholino oligomem [J]. Bioconjug Chem,2002, 13(4): 893-897.
  • 9Abrams M J, Juweid M, Abrams M J, et al. Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats[J]. J Nucl Med, 1990, 31(12): 2022-2028.
  • 10Edwards DS, Liu S. ^99mTc-labelling of hydrazinonicotinamide(HYNIC) modified highly potent small molecules: problems and solutions[J]. Transition Met Chem, 1997, 22(4): 425--426.

二级参考文献16

  • 1Wang XB. Preparation and applied prospect of radiopharmaceuticals labeled with 99Tcm [J]. Chin J Nul Med (中华核医学杂志), 1997,17(1):1-3.
  • 2Schneider RF, Subramanian G, Feld TA, et al. N,N′-Bis(S-benzoylmercaptoacetamido) ethylenediamine and pro-pylenediamine ligands as renal function imaging agents [J]. J Nul Med, 1984,25(2):223-229.
  • 3Liu S, D. Scott E, Loody RJ, et al. Ladelinf cyclic glycoprotein IIb/IIIa receptor antagonists with 99Tcm by the preforned chelate approach: effects of chelators on properties of [99Tcm]chelator-peptide conjugates [J]. Bioconjugate Chem, 1996,7(2):196-202.
  • 4Luyt LG, Jenkins HA, Hunter DH. An N2S2 bifunctional chelator for Technetium-99m and rhenium: complexation,conjugation and epimerization to a single isomer [J]. Bioconjugate Chem, 1999,10(3):470-479.
  • 5Cumming SA, Nechvatal G, Canning LR, et al. Development of Technetium-99m regional cerebral blood flow agents based on the propylene-amine-oxome ligend (PnAO) [J]. Eur J Nucl Med, 1985,11(2):A107.
  • 6Canning LR, Nechvatal G, Cumming SA, et al. Technetium-99m-hexamethyl-propyleneamine-oxime (99mTc-HMPAO): A new radiopharmaceutical for RCBF imaging [J]. Nucl Medizin, Suppl. (stutlgart), 1986,22(2):173-175.
  • 7Cheesman EH, Blanchette MA, Ganey MV, et al. Technetium-99m ECD: ester-derivation diamine-dithiol Tc complexes for imaging brain perfusion [J]. J Nucl Med, 1988,299(4):788.
  • 8Capretta A, Maharajh RB, Bell RA. Synthesis and characterization of cyclomaltoheptaose-based metal chelants as prokes for intestinal permeability [J]. Carbohydr Res, 1995,267(1):49-63.
  • 9Zervas L, Photaki I. On cysteine and cystine peptides. I. New S-protecting groups for cysteine [J]. J Am Chem Soc, 1962,84(20):3887-3897.
  • 10Crudo JL,Edreira MM,Obenaus ER,et al.Optimization of antibody labeling with rhenium-188 using a prelabeled MAG3 chelate[].International Journal of Pharmaceutics.2002

共引文献6

同被引文献33

  • 1高再荣,张凯军,张永学.MAG_3和DTPA用于^(99)Tc^m标记Survivin ASON的对比研究[J].中华核医学杂志,2004,24(4):238-241. 被引量:5
  • 2张弢,王毅,褚泰伟,刘新起,胡少文,王祥云.潜在的新型肿瘤显像剂^(99)mTc-MAG_3-GGCNGRC的合成及生物分布[J].高等学校化学学报,2005,26(5):801-805. 被引量:2
  • 3Shibuya M. Differential roles of vascular endothelial growth factor re- ceptor-1 and receptor-2 in angiogenesis [ J ]. J Biochem Mol Biol, 2006, 39 (5) : 469 -478.
  • 4Liu L, Zhu D, Gao R, et al. Expression of vascular endothelial growth factor, receptor KDR and p53 protein in transitional cell carcinoma of the bladder[J]. Urol Int, 2008, 81 ( 1 ) : 72 -76.
  • 5Giatromanolaki A, Koukourakis M 1, Sivridis E, et al. Activated VEG- FR2/KDR pathway in turnout cells and tumour associated vessels of eolorectal cancer[ J ] . Eur J Clin Invest, 2007, 37 (11 ) : 878 -886.
  • 6An S J, Nie Q, Chen Z H, et al . KDR expression is associated with the stage and cigarette smoking of the patients with lung cancer[ J ] . J Cancer Res Clin Oncol , 2007, 133(9) : 635 -642.
  • 7Inan S, Vatansever S, Celik-Ozenci C, et al . Immunolocalizations of VEGF, its receptors fit-1, KDR and TGF-beta' s in epithelial ovarian tumors[ J] . Histol Histopathol , 2006, 21 (10) : 1055 - 1064.
  • 8Ozdemir F, Akdogan R, Aydin F, et al. The effects of VEGF and VEGFR-2 on survival in patients with gastric cancer[ J]. J Exp Clin Cancer Res, 2006, 25 ( 1 ) : 83 - 88.
  • 9Damiano V, Melisi D, Bianco C, et al. Cooperative antitumor effect of multitargeted kinase inhibitor ZD6474 and ionizing radiation in glioblastoma[ J] . Clin Cancer Res, 2005, 11 ( 15 ) : 5639 - 5644.
  • 10Hetian L, Ping A, Shumei S, et al. A novel peptide isolated from a phage display library inhibits tumor growth and metastasis by blocking the binding of vascular endothelial growth factor to its kinase domain receptor[ J]. J Biol Chem, 2002, 277(45) : 43137 -43142.

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部